HRI awarded prestigious $100,000 grant by Ramaciotti Foundations
Congratulations to Dr Xuyu (Johnny) Liu, Unit Leader at the Heart Research Institute, who has been awarded a $100,000 Health Investment Grant from the Clive & Vera Ramaciotti Foundations.
World-first exercise study shows benefits for patients with congenital heart disease
The Heart Research Institute’s (HRI’s) world-first exercise trial for patients with congenital heart disease (CHD) is already seeing positive results, with participants reporting increased energy and reduced anxiety while being active.
HRI’s Prof Andrew Coats named as Australia’s top cardiology researcher
The Heart Research Institute’s Scientific Director and CEO Prof Andrew Coats has been recognised as Australia’s top researcher in cardiology for the second year running.
HRI members celebrated at AAS, ANZMS and AVBS Joint Meeting
Several members of the Heart Research Institute (HRI) have presented and been awarded at the special AAS, ANZS, AVBS Joint Meeting held in the Adelaide Hills.
Prof David Celermajer receives $400,000 funding from Vasudhara Foundation
The Heart Research Institute (HRI) has received a gift of $400,000 from the Vasudhara Foundation to support the work of esteemed cardiologist and researcher, Prof David Celermajer AO.
“It’s personal”: The young researcher examining new age blood thinners to prevent stroke
Cameron Trought thinks being rejected from medical school was the best thing that ever happened, as he now works alongside world-leading scientists in stroke research.
‘Discovery’ mass spectrometer system now live in HRI’s Fluxomics Centre
The cutting-edge liquid chromatography-mass spectrometer system in HRI's Fluxomics Centre will allow researchers to deeply analyse molecular changes in CVD over time.
Leading cause of death in Australia: Heart disease insights
Heart disease remains the leading cause of death in Australia, according to figures released this week by the Australian Bureau of Statistics (ABS).
Research assistant Michael Hutton publishes review on atherosclerosis research
In HRI’s Atherosclerosis and Vascular Remodelling Group, research assistant Michael Hutton and Dr Ashish Misra have published a review on new targets in the treatment of atherosclerosis.